These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 16342465)

  • 1. Postcards from the cutting edge.
    Suprun SC
    Emerg Med Serv; 2005 Nov; 34(11):65-7. PubMed ID: 16342465
    [No Abstract]   [Full Text] [Related]  

  • 2. Is aspirin part of your chest pain protocol?
    Bledsoe BE
    Emerg Med Serv; 2003 Feb; 32(2):52-3. PubMed ID: 12619249
    [No Abstract]   [Full Text] [Related]  

  • 3. Prehospital Fibrinolysis in concert with rapid PCI. Clinical trial shows promising results for use of clot-dissolving agents in the field.
    Persse DE; McCarthy JJ; Vooletich M; Richter BK; Anderson HV; Denktas AE; Sdringola SM; Smalling RW
    JEMS; 2008 Mar; 33(3):74-88. PubMed ID: 18328399
    [No Abstract]   [Full Text] [Related]  

  • 4. Sit up for a pulse. When congestive heart failure fells the boss, well-meaning colleagues make a bad situation worse.
    Augustine JJ
    EMS Mag; 2007 May; 36(5):28, 30. PubMed ID: 17536581
    [No Abstract]   [Full Text] [Related]  

  • 5. Preventing under-equipped medical facilities from killing heart attack patients: correcting inefficiencies in the current regulatory paradigm for providing critical health care services to patients with acute coronary syndrome.
    Steinbuch R
    Health Matrix Clevel; 2007; 17(1):17-62. PubMed ID: 17849816
    [No Abstract]   [Full Text] [Related]  

  • 6. Update on stroke: the latest guidelines.
    Granitto M; Galitz D
    Nurse Pract; 2008 Jan; 33(1):39-46; quiz 47. PubMed ID: 18192863
    [No Abstract]   [Full Text] [Related]  

  • 7. Drugs for treatment of heart failure.
    Treat Guidel Med Lett; 2006 Jan; 4(41):1-4. PubMed ID: 16374402
    [No Abstract]   [Full Text] [Related]  

  • 8. Metabolic approach in heart failure: rethinking how we translate from theory to clinical practice.
    Tang WH
    J Am Coll Cardiol; 2006 Sep; 48(5):999-1000. PubMed ID: 16949493
    [No Abstract]   [Full Text] [Related]  

  • 9. Antithrombotics for left-ventricular impairment.
    Lip GY; Gibbs CR
    Lancet; 1998 Sep; 352(9130):817-8. PubMed ID: 9737312
    [No Abstract]   [Full Text] [Related]  

  • 10. Fibrinolytic agents for the management of ST-segment elevation myocardial infarction.
    Hilleman DE; Tsikouris JP; Seals AA; Marmur JD
    Pharmacotherapy; 2007 Nov; 27(11):1558-70. PubMed ID: 17963464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombolysis in stroke: still not ready for community hospital use by emergency physicians.
    McNamara RM
    Ann Emerg Med; 2009 Sep; 54(3):339-41. PubMed ID: 19695417
    [No Abstract]   [Full Text] [Related]  

  • 12. Estimation of Iranian stroke patients eligible for intravenous thrombolysis with tPA.
    Ghandehari K; Zahed AP; Taheri M; Abbasi M; Gorjestani S; Ahmadi AM; Nahayati MA
    Int J Stroke; 2009 Aug; 4(4):236. PubMed ID: 19689746
    [No Abstract]   [Full Text] [Related]  

  • 13. Reperfusion of acute myocardial infarction in North Carolina emergency departments (RACE): study design.
    Jollis JG; Mehta RH; Roettig ML; Berger PB; Babb JD; Granger CB
    Am Heart J; 2006 Nov; 152(5):851.e1-11. PubMed ID: 17070144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IV tissue plasminogen activator use in acute stroke: experience from a statewide registry.
    Reid JM; Gubitz GJ; Phillips SJ
    Neurology; 2006 Nov; 67(9):1724-5; author reply 1724-5. PubMed ID: 17101926
    [No Abstract]   [Full Text] [Related]  

  • 15. The pharmaco-invasive approach to STEMI: when should fibrinolytic-treated patients go to the "cath lab"?
    Edmond JJ; Juergens CP; French JK
    Postgrad Med J; 2009 Jun; 85(1004):331-4. PubMed ID: 19528310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accelerating time to reperfusion in acute myocardial infarction: prehospital and emergency department strategies, systems of care, and pharmacologic interventions.
    Ornato JP
    Rev Cardiovasc Med; 2006; 7 Suppl 4():S49-60. PubMed ID: 17224891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of fibrinolytic therapy in the current era of ST-segment elevation myocardial infarction management.
    Smalling RW
    Am Heart J; 2006 Jun; 151(6 Suppl):S17-23. PubMed ID: 16777505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pharmaco-invasive approach to STEMI: when should fibrinolytic-treated patients go to the "cath lab"?
    Edmond JJ; Juergens CP; French JK
    Heart; 2009 Mar; 95(5):358-61. PubMed ID: 18467356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emergency physician survey: recombinant tissue plasminogen activator for stroke.
    Walsh M; Fromm G
    Ann Emerg Med; 2006 Mar; 47(3):297. PubMed ID: 16492504
    [No Abstract]   [Full Text] [Related]  

  • 20. Prehospital fibrinolytic therapy followed by urgent percutaneous coronary intervention in patients with ST-elevation myocardial infarction.
    Yeter E; Denktas AE
    Future Cardiol; 2009 Jul; 5(4):403-11. PubMed ID: 19656064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.